A phase I/II trial of 5-fraction stereotactic radiosurgery with 5-mm margins with concurrent temozolomide in newly diagnosed glioblastoma: primary outcomes - Concepedia

Concepedia

Publication | Open Access

A phase I/II trial of 5-fraction stereotactic radiosurgery with 5-mm margins with concurrent temozolomide in newly diagnosed glioblastoma: primary outcomes

DOI Full Paper Access

61

Citations

31

References

2020

Year

M. Azoulay, Daniel T. Chang, Iris C. Gibbs, Steven Hancock, Erqi L. Pollom, Griffith R. Harsh, John R. Adler, Ciara Harraher, Gordon Li, Melanie Hayden Gephart,

Abstract

The per-protocol MTD of 5-fraction SRS with 5-mm margins with concurrent temozolomide was 40 Gy in 5 fractions. ARE was limited to grades 1-2 and did not statistically impact survival.

References

	Year	Citations

Page 1